Femasys Inc
FEMY- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001339005
In the last 90 days, Femasys Inc insiders filed 5 open-market purchases and 0 sales; 19 institutions reported holding it in 13F filings for Q2 2026, worth $8.65M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Femasys Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 18 | 17 | −1 |
| Shares | 831.7K | 894.1K | +62.4K (+7.5%) |
| Value | $2.00M | $1.01M | −$993.3K (−49.6%) |
New holders (4)
Institutions that held Femasys Inc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mariner, LLC | 37,476 | $42.0K | 0.00% |
| Whittier Trust Co of Nevada Inc | 15,881 | $18.0K | 0.00% |
| Goldman Sachs Group Inc | 13,234 | $15.0K | 0.00% |
| Creative Planning | 10,526 | $12.0K | 0.00% |
Sold out (5)
Institutions that held Femasys Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Virtu Financial LLC | 16,002 | $39.0K |
| Citadel Advisors LLC | 15,787 | $38.0K |
| StoneX Group Inc. | 10,227 | $24.6K |
| Citigroup Inc | 8,849 | $21.0K |
| JPMorgan Chase & Co | 32 | $0 |